What an inspiring group of people! Thank you Forbes Under 30 for the nomination. With Theolytics we're committed to transforming patients' lives, through world leading science, with a great team. #science #healthcare #biotech #ForbesUnder30 forbes.com/30-under-30/20…

Airborne it is. 🦠 The 10 streams of overwhelming evidence thelancet.com/journals/lance… The Lancet by Trisha Greenhalgh Kimberly Prather, Ph.D. @Rschooley zeynep tufekci Prof. Jose-Luis Jimenez @dfisman a 5-★ succinct summary

Who knew one team had so many fantastic wildlife photographers? In honour of #earthday2021 you can check out some of our team's best shots of Planet Earth #conservation #team #environment #naturephotography

We're delighted to announce that we're taking part in the BioIndustry Association (BIA) #ResearchRelay2021 to raise money for Ovarian Cancer Action - we'll be attempting to walk 2000km over May 🏃🚵 You can donate to our teams by following the links below: bit.ly/3h9iNrO bit.ly/3nWhb6e

Thank you to The RSA Group for their thoughtful questions - we covered a lot of ground in this conversation! The value of challenge, creating space for serendipity, and how striving for ambitious goals allows us to surprise even ourselves sometimes. #biotech #leadership #startups

A great opportunity to have on the radar for data-driven start-ups! #startup #datascience #accelerator

Working together to overcome the sixth most common cancer in women - thank you to everyone that supported our team with the Ovarian Cancer Action Research Relay last month!

Thank you Nature Biotechnology for the opportunity to make a prediction about the future of our sector! Great to share a few thoughts alongside Bill Gates @DrMichelleBIO Jacob Venter george church & many brilliant others! #oncology #genetherapy #vaccines #diversity nature.com/articles/s4158…

A warm welcome to the Merck team. This investment further validates the breakthrough potential of Theolytics’ technology, and will enable us to accelerate our progress developing transformative therapies for patients in need. theolytics.com/news/theolytic… #biotech #innovation

Summer internship (August) - opportunity for a motivated individual to gain hands-on microbiology experience, contributing to our lead programme for ovarian cancer - set up PCR reactions, run DNA gels, extraction & purification of DNA, cloning. Reach out to [email protected]

Dynamic, self-starter with lab management ambition - we are seeking a Deputy Lab Manager to join our team. Check out the role on our website now bit.ly/3Anbwev

🚀 Join us Nov 3 for our hybrid panel discussion 🧬! 🇬🇧🇺🇸 “Route into Entrepreneurship - Building a #Startup in the #US or #UK” with Stephen Chambers IndieBio, Tony de Fougerolles Evox Therapeutics & Charlotte Casebourne Stock Theolytics ✔️ Register now: eventbrite.co.uk/e/route-into-e… #innovation #science

👏 🚀💡 Thank you to all participants, panellists & CSEN team for making yesterday's panel discussion “Route into #Entrepreneurship - Building a #Startup in the UK or US 🇬🇧🇺🇸” with Stephen Chambers IndieBio, Tony de Fougerolles Evox Therapeutics & Charlotte Casebourne Stock Theolytics a big success 🧬!

We're seeking a Bioinformatician to join our team at Theolytics! If you're interested in transforming patients' lives through world leading science, we want to hear from you. #oncology #bioinformatics #hiring #recruitment

Charlotte Casebourne Stock, CEO of Theolytics, joins us on the Careers in Discovery podcast to discuss: - solving the in vivo translation problem - why it's OK not to know what you want to do - the importance of finding your rhythm Head to anchor.fm/careers-in-dis… to listen. Enjoy! #Career

Huge congratulations to our Chair - Ken Powell - and the team @ReViral_ltd. They're on a mission developing antiviral therapies to help the world’s most at-risk populations, now in partnership with Pfizer Inc. 🎊 #biotech #therapeutics #antiviral

We're recruiting a Head of Regulatory Affairs! This position is an excellent opportunity for someone looking to take leadership responsibility, working with an interdisciplinary team to develop new cancer treatments. lnkd.in/eMjAayHe #recruiting #regulatory

We're kicking-off a £1M project in collaboration with The University of Sheffield and @lawson_ma this month, supported by Innovate UK, to develop a novel therapy for multiple myeloma patients in need. theolytics.com/post/1m-projec… #biotech #oncology #viral #medicine

We’ll be presenting a promising new therapy for stromal rich tumours IOVC this month, and today warmly welcome Andrew, CFO and Miriam, VP Translational Development to the Theolytics team #biotech #cancer #drugdiscovery

We are delighted to share our recent results on our lead oncolytic virus (THEO-260) ASCO and present our datasets European Hematology Association on THEO-310 Exciting times for the Theolytics team! theolytics.com/post/theolytic… #ASCO #EHA #oncology #oncolyticvirus #ovariancancer #TME #myeloma